Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1

Inhibiting human immunodeficiency virus type 1 (HIV-1) infection by blocking the host cell coreceptors CCR5 and CXCR4 is an emerging strategy for antiretroviral therapy. Currently, several novel coreceptor inhibitors are being developed in the clinic, and early results have proven promising. In this...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Strizki, Julie M., Tremblay, Cecile, Xu, Serena, Wojcik, Lisa, Wagner, Nicole, Gonsiorek, Waldemar, Hipkin, R. William, Chou, Chuan-Chu, Pugliese-Sivo, Catherine, Xiao, Yushi, Tagat, Jayaram R., Cox, Kathleen, Priestley, Tony, Sorota, Steve, Huang, Wei, Hirsch, Martin, Reyes, Gregory R., Baroudy, Bahige M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2005
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1315929/
https://ncbi.nlm.nih.gov/pubmed/16304152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.12.4911-4919.2005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky